Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition

Source: MDLinx, November 2019

Among women enrolled in the European Prospective Investigation into Cancer and Nutrition, a prospective cohort analysis started in 1992 in 10 European countries, researchers investigated the links between the use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk. A total of 334,483 women with 1,696 melanoma cases were identified over 1992–2015, including 134,758 postmenopausal women with 770 cases. A positive, borderline-significant link between OC use and melanoma risk was observed, with no identified heterogeneity across countries. With the duration of use, a linear rise in this risk was noted.

Read the original full article

2019 Events

Calculate your risk of getting melanoma Sunscreen calculator
Map of body for recording areas of skin causing you concern on your body Target Therapy Finder